Blockade of receptor for advanced glycation end products protects against systolic overload-induced heart failure after transverse aortic constriction in mice
Blockade of receptor for advanced glycation end products protects against systolic overload-induced heart failure after transverse aortic constriction in mice
复制标题
阻断晚期糖基化终末产物受体可预防小鼠横主动脉缩窄后收缩超负荷诱发的心力衰竭
DOI:
10.1016/j.ejphar.2016.07.008
复制
发表时间:
2016-11-15
影响因子:
5
通讯作者:
Zhao, Xianxian
中科院分区:
文献类型:
--
作者:
Liu, Yu;Yu, Manli;Zhao, Xianxian
Heart failure is the consequence of sustained, abnormal neurohormonal and mechanical stress and remains a leading cause of death worldwide. The aim of this work was to identify whether blockade of receptor for advanced glycation end products (RAGE) protected against systolic overload -induced heart failure and investigate the possible underlying mechanism. It was found that RAGE mRNA and protein expression was up -regulated in cardiac tissues from mice subjected to pressure overload by transverse aortic constriction (TAC). Importantly, inhibition of RAGE by treatment with soluble RAGE (sRAGE) or FPS-ZM1 (a high -affinity RAGE -specific inhibitor) for 8 weeks attenuated cardiac remodeling (including cardiac hypertrophy and fibrosis), and dysfunction in mice exposed to TAC. Furthermore, treatment of TAC mice with sRAGE or FPS-ZM1 enhanced phosphorylation of AMPK and reduced phosphorylation of mTOR and protein expression of NF kappa B p65 in cardiac tissues. In addition, treatment of TAC mice with sRAGE or FPS-ZM1 abated oxidative stress, attenuated endoplasmic reticulum stress, and suppressed inflammation in cardiac tissues. These data demonstrated the benefits of blocking RAGE on the progression of systolic overload -induced heart failure in mice, which was possibly through modulating AMPK/mTOR and NF kappa B pathways. (C) 2016 Elsevier B.V. All rights reserved.